D61.810 - Antineoplastic chemotherapy induced pancytopenia

Applicable to Antineoplastic chemotherapy induced pancytopenia
The 2025 edition of ICD10-CM D61.810 became effective on October 1, 2024.
This is the American ICD10-CM version of D61.810 - other international versions of ICD10 D61.810 may differ.
D61.810 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Type 2 Excludes

aplastic anemia due to antineoplastic chemotherapy (D61.1)

The following codes above D61.810 contain annotation back-references that may be applicable to D61.810:

Chapter: D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Section: D60-D64 Aplastic and other anemias and other bone marrow failure syndromes

Category: D61 Other aplastic anemias and other bone marrow failure syndromes

antineoplastic icd 10

chemotherapy icd 10

pancytopenia icd 10

Billable/Specific Code

Browse other similar CM codes

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Please, give attribution to our website icd-10code.com